We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $145B
1-Year Est. Return 34.61%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
-5.51%
1 Year Est. Return
+34.61%
3 Year Est. Return
+158.21%
5 Year Est. Return
+226.99%
10 Year Est. Return
+1,390.17%
AUM
$97.6B
AUM Growth
-$11.5B
Cap. Flow
-$2.7B
Cap. Flow %
-2.76%
Top 10 Hldgs %
24.06%
Holding
813
New
84
Increased
272
Reduced
353
Closed
92

Sector Composition

Rank Sector Weight
1 Healthcare 19.08%
2 Consumer Discretionary 17.25%
3 Communication Services 14.3%
4 Technology 13.13%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
776
Walmart Inc
WMT
$909B
-146,682
Closed -$3.47M
XBI icon
777
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
-750,000
Closed -$63.1M
XYL icon
778
Xylem
XYL
$28.5B
-13,148
Closed -$487K
SMC
779
Summit Midstream
SMC
$420M
-6,896
Closed -$3.42M
CBAY
780
DELISTED
Cymabay Therapeutics
CBAY
-858,786
Closed -$2.31M
ACOR
781
DELISTED
Acorda Therapeutics
ACOR
-2,252
Closed -$9.01M
BLCM
782
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-27,573
Closed -$5.87M
TEN
783
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-47,254
Closed -$2.71M
KRA
784
DELISTED
Kraton Corporation
KRA
-33,805
Closed -$807K
FIT
785
DELISTED
Fitbit, Inc. Class A common stock
FIT
-594,748
Closed -$22.7M
VSLR
786
DELISTED
VIVINT SOLAR, INC.
VSLR
-1,415,607
Closed -$17.2M
TTPH
787
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-56,141
Closed -$53.3M
TUES
788
DELISTED
Tuesday Morning Corp
TUES
-1,061,197
Closed -$12M
ESL
789
DELISTED
Esterline Technologies
ESL
-6,164
Closed -$588K
LHO
790
DELISTED
LaSalle Hotel Properties
LHO
-101,059
Closed -$3.58M
SHLM
791
DELISTED
Schulman (A.) Inc
SHLM
-14,462
Closed -$632K
RATE
792
DELISTED
Bankrate Inc
RATE
-79,999
Closed -$839K
PRXL
793
DELISTED
Parexel International Corp
PRXL
-7,531
Closed -$484K
WFM
794
DELISTED
Whole Foods Market Inc
WFM
-8,999
Closed -$355K
YHOO
795
DELISTED
Yahoo Inc
YHOO
-3,101,237
Closed -$122M
SGNT
796
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
-17,726
Closed -$431K
XNPT
797
DELISTED
XENOPORT, INC.
XNPT
-443,432
Closed -$2.72M
BDBD
798
DELISTED
BOULDER BRANDS INC
BDBD
-123,269
Closed -$855K
TW
799
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
-352,568
Closed -$44.4M
ALTR
800
DELISTED
Altera Corp
ALTR
-786,207
Closed -$40.3M

Similar funds

Jennison Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
  • Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
  • Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
  • Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
  • Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
  • Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
  • Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.

Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.